Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats

Obesity Research

Volumn 8, Issue 9, 2000, Pages 656-663

  Picard, Frédéric ^a   Deshaies, Yves ^a   Lalonde, Josée ^a   Samson, Pierre ^a   Richard, Denis ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Adipose tissue; Anticonvulsant drug; Body composition; Energy expenditure; Food intake

Indexed keywords

ANTIOBESITY AGENT; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; CALORIC INTAKE; COHORT ANALYSIS; DOSE RESPONSE; DRUG EFFECT; ENERGY METABOLISM; FEEDING BEHAVIOR; FEMALE; OBESITY; PATHOPHYSIOLOGY; RAT; SKELETAL MUSCLE; TIME; WEIGHT GAIN; ZUCKER RAT;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY INTAKE; ENERGY METABOLISM; FEEDING BEHAVIOR; FEMALE; FRUCTOSE; MUSCLE, SKELETAL; OBESITY; RATS; RATS, ZUCKER; TIME FACTORS; WEIGHT GAIN;

EID: 0034576649     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2000.84     Document Type: Article

References (30)

1. Gordon A, Price LH. Mood stabilization and weight loss with topiramate. Am J Psychiatry. 1999;156:968-9.
2. Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology. 1999;53:S53-67.
3. Baulac M, Arzimanoglou A, Semah F, Cavalcanti D. Therapeutic options provided by new antiepileptic drugs. Rev Neurol. 1997;155:21-33.
4. Shank RJ, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia. 2000;41:S3-9.
5. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 1999;52:1330-7.
6. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked currents in mouse brain neurons and increases seizure threshold. Epilepsy Res. 1997;28:167-79.
7. White HS, Skeen GA, Woodhead J, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by non-benzodiazepine mechanism. Epilepsia. 2000;41: S17-20.
8. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia. 2000; 41:S10-6.
9. Skradski S, White HS. The novel antiepileptic drug topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia. 2000;41:S45-7.
10. + current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther. 2000;288:960-8.
11. Zona C, Ciotti MT, Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells in culture. Neurosci Lett. 1997;231:123-6.
12. DeLorenzo RJ, Sombati S, Coulter DA. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia. 2000;41:S40-4.
13. Wu SP, Tsai JJ, Gean PW. Frequency-dependent inhibition of neuronal firing by topiramate in hippocampal slices. Br J Pharmacol. 1999;125:826-32.
14. McLean MJ, Bukhari AA, Wamil AW. Effects of topiramate on sodium-dependent action potential firing by mouse spinal cord neurons in cell culture. Epilepsia. 2000; 41:S21-4.
15. Zhang XL, Velumian A, Jones OT, Carlen PL. Modulation of high voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia. 2000;41:S52-60.
16. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isozymes. Epilepsia. 2000;41: S35-9.
17. Stanley BG, Butterfield BS, Grewal RS. NMDA receptor coagonist glycine site: evidence for a role in lateral hypothalamic stimulation of feeding. Am J Physiol. 1997;273:R790-6.
18. Deshaies Y, Dagnault A, Lalonde J, Richard D. Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat. Am J Physiol. 1997;36:E355-62.
19. Dagnault A, Deshaies Y, Richard D. Effects of the 5-hydroxytryptamine agonist dl-fenfluramine on energy balance in rats: influence of gender. Int J Obes. 1993;17:367-73.
20. Lofti M, MacDonald IA, Stock MJ. Energy losses associated with oven-drying and the preparation of rat carcasses for analysis. Br J Nutr. 1976;36:305-9.
21. Webster AJF. Energetics of maintenance and growth. In: Girardier L, Stock M, eds. Mammalian Thermogenesis. London: Chapman and Hall; 1983, pp. 178-207.
22. Barr HG, Mckracken KJ. High efficiency of energy utilization in "cafeteria"-and force-fed rats kept at 29°. Br J Nutr. 1984;51:379-87.
23. Murphy BEP. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassays. J Clin Endocrinol Metab. 1967; 27:973-90.
24. Richard D. Effects of ovarian hormones on energy balance and brown adipose tissue thermogenesis. Am J Physiol. 1986; 250:R245-9.
25. Griggio MA, Richard D, LeBlanc J. Effects of fasting and food restriction on sympathetic activity in brown adipose tissue in mice. J Comp Physiol B. 1992;162:602-6.
26. Czech MP, Richardson DK, Becker SG, Walters CG, Gitomer W, Heinrich J. Insulin response in skeletal muscle and fat cells of the genetically obese Zucker rat. Metabolism. 1978;27:1967-81.
27. Timofeeva E, Richard D. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinology. 1997;66:327-40.
28. Schneiderman JH. Topiramate: pharmacokinetics and pharmacodynamics. Can J Neurol Sci. 1998;25:S3-5.
29. Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res. 1997;35: 241-56.
30. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther. 1997:19:523-4, 1294-308.